ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 165 filers reported holding ACORDA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,608,000 | -18.1% | 271,466 | -4.0% | 0.01% | -25.0% |
| Q4 2018 | $4,407,000 | +3834.8% | 282,844 | +4875.3% | 0.01% | – |
| Q3 2018 | $112,000 | -99.9% | 5,685 | +147.0% | 0.00% | – |
| Q1 2014 | $87,269,000 | +29.8% | 2,302 | 0.0% | 0.00% | – |
| Q4 2013 | $67,218,000 | +873.0% | 2,302 | +1039.6% | 0.00% | – |
| Q3 2013 | $6,908,000 | – | 202 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |